Suppr超能文献

了解增强营养供给对高滴度抗体生产过程的细胞内影响。

Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process.

机构信息

Oceanside Pharma Technical Development, Genentech, Inc., Oceanside, California 92056, USA.

出版信息

Biotechnol Bioeng. 2011 May;108(5):1078-88. doi: 10.1002/bit.23031. Epub 2011 Feb 19.

Abstract

One of the major goals in cell culture process development for therapeutic antibody production is to develop methods to reach high titer in classical fed-batch processes. This goal is often achieved through the optimizations of expression vector, cell line, media and cell culture process controls to increase cell specific productivity, viable cell density, and culture longevity. During process optimization for a selected production cell line, cell specific productivity (qP) can vary significantly with culture conditions. Therefore, identifying strategies to maintain maximal specific productivity throughout the entire fed-batch culture and to eliminate cellular/process bottlenecks that prevent high levels of antibody production would be crucial for further advancements in this area. In this work, specific productivity was increased and maintained at high level throughout the course of the culture by the optimization of feed media and feeding strategy. Through the enhancement of nutrient feeding, final titer was increased by 2.5-fold from the platform fed-batch process and reached 7.5 g/L. In addition, further insight upon possible cellular bottlenecks in high yield antibody production was obtained by comparing the levels of heavy chain (HC) and light chain (LC) mRNA and the levels of intracellular antibody between the non-optimized and optimized feeding processes. The mRNA levels of the two processes were measured and exhibited no significant difference suggesting that transcription is not the bottleneck. When intracellular antibody level was studied, the relatively constant level of HC, LC, and intact antibody between days 9 and 14 suggested that translation could be the rate-limiting step under the non-optimized nutrient feeding condition due to the dramatic drop of qP to roughly zero which correlated with the depletion of tyrosine as one of the key amino acids for protein synthesis. Finally, accumulation of unassembled HC but not intact antibody was observed at days 14-18 under the enhanced feeding condition, implying that folding and assembly may be the bottleneck toward the end of the culture.

摘要

在治疗性抗体生产的细胞培养工艺开发中,主要目标之一是开发方法以在经典补料分批工艺中达到高滴度。这一目标通常通过优化表达载体、细胞系、培养基和细胞培养过程控制来实现,以提高细胞特异性产率、活细胞密度和培养寿命。在选定的生产细胞系的工艺优化过程中,细胞特异性产率 (qP) 会随培养条件而显著变化。因此,确定在整个补料分批培养过程中保持最大特异性产率的策略,并消除阻止抗体高产量产生的细胞/工艺瓶颈,对于该领域的进一步发展至关重要。在这项工作中,通过优化补料培养基和补料策略,提高了特异性产率,并在整个培养过程中保持在高水平。通过增强营养物补料,最终滴度比平台补料分批工艺提高了 2.5 倍,达到 7.5 g/L。此外,通过比较非优化和优化补料过程中重链 (HC) 和轻链 (LC) mRNA 水平以及细胞内抗体水平,进一步了解高产抗体生产中可能存在的细胞瓶颈。测量了两个过程的 mRNA 水平,发现没有显著差异,表明转录不是瓶颈。当研究细胞内抗体水平时,在第 9 天至第 14 天之间,HC、LC 和完整抗体的水平相对恒定,这表明在非优化的营养物补料条件下,翻译可能是限速步骤,因为 qP 急剧下降到几乎为零,这与酪氨酸的消耗有关,酪氨酸是蛋白质合成的关键氨基酸之一。最后,在增强的补料条件下,在第 14 天至第 18 天观察到未组装的 HC 积累,但没有完整抗体,这意味着折叠和组装可能是培养结束时的瓶颈。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验